Biomedical Engineering Reference
In-Depth Information
[3] Wang W, Singh SK, Zeng DL, King K, Nema S. Antibody structure, instability and
formulation. J Pharm Sci 2007;96:1-26.
[4] Fransson J, Hagman A. Oxidation of human insulin-like growth factor I in formulation
studies. II. effect of oxygen, visible light and phosphate on methionine oxidation and
evaluation of possible mechanisms. Pharm Res 1996;13:1476-1481.
[5] Gupta S, Kaisheva E. Development of a multidose formulation for a humanized monoclonal
antibody using experimental design techniques. AAPS PharmSciTech 2003;5:74-82.
[6] Srivastava A, Goldstein J, Agarkhed M, Pirrotta D, Rivera J, Wojcik R, Pan G, Tracy S,
Zhou Q, Tarnowski J. Development of a freeze dried formulation to protect against
non-enzymatic hinge region cleavage for a monoclonal antibody. Poster Presentation,
National Biotechnology Conference, Boston, MA, AAPS, 2006.
